Results 31 to 40 of about 79,986 (50)

Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action. [PDF]

Int J Mol Sci, 2021
Łukasik P, Baranowska-Bosiacka I, Kulczycka K, Gutowska I.   +3 more
europepmc   +1 more source

Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma. [PDF]

BMC Gastroenterol, 2022
Wei ZL, Zhou X, Lan CL, Huang HS, Liao XW, Mo ST, Wei YG, Peng T.   +7 more
europepmc   +1 more source

Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Carcinoma. [PDF]

Cancers (Basel)
Barton WC, Kumari A, Mack ZT, Schools GP, Quintero LM, Choi AS, Rangavajhula K, Arend RC, Broude EV, Mythreye K.   +9 more
europepmc   +1 more source

Phosphorylation of mixed lineage kinase MLK3 by cyclin-dependent kinases CDK1 and CDK2 controls ovarian cancer cell division. [PDF]

J Biol Chem, 2022
Cedeno-Rosario L, Honda D, Sunderland AM, Lewandowski MD, Taylor WR, Chadee DN.   +5 more
europepmc   +1 more source

Cyclin-dependent kinases (CDKs) are key genes regulating early development of Neptunea arthritica cumingii: evidence from comparative transcriptome and proteome analyses. [PDF]

BMC Genomics
Lv F, Ge X, Chang Y, Hao Z.
europepmc   +1 more source

Verification of cell cycle-associated cyclin-dependent kinases facilitated prostate cancer progression by integrated bioinformatic analysis and experimental validation. [PDF]

Heliyon, 2022
Huang Y, Lu S, Chen Y, Qing Y, Wu R, Ma T, Zhang Z, Wang Y, Li K.   +8 more
europepmc   +1 more source

Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer - A Clinical Review. [PDF]

Curr Treat Options Oncol
Benvenuti C, Grinda T, Rassy E, Dixon-Douglas J, Ribeiro JM, Zambelli A, Santoro A, Pistilli B.   +7 more
europepmc   +1 more source

Development of a Radiolabeled Cyclin-Dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Brain and Cancer PET Imaging. [PDF]

Int J Mol Sci
Huang CH, Khan P, Xu S, Cohen J, Georgakis GV, Turkman N.   +5 more
europepmc   +1 more source

Spectrum of psychiatric adverse reactions to cyclin-dependent kinases 4/6 inhibitors: A pharmacovigilance analysis of the FDA adverse event reporting system. [PDF]

CNS Neurosci Ther
Xiao Z, Cao J, Wu S, Zhou T, Li C, Duan J, Yang Z, Xu F.   +7 more
europepmc   +1 more source

Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods. [PDF]

Pathol Oncol Res, 2022
Gao L, Chen G, Liang ZQ, Li JD, Li DM, Tang YL, Tang D, Huang ZG, Chen JH, Luo JY, Zeng JH, Dang YW, Feng ZB.   +12 more
europepmc   +1 more source